A recent study from the Laboratory of Gene Regulation and Signal Transduction, University of California, San Diego, La Jolla, California 92093; Departments of Pharmacology and Pathology, University of California, San Diego, La Jolla, California 92093; and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, USA shows that “A gp130-Src-YAP module links inflammation to epithelial regeneration.” This study was published in the 5 March 2015 issue of the Journal “Nature” [I.F:42] by Prof. Michael Karin, Dr. Koji Taniguchi, and others.
On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: MiRNA-based regenerative therapy for Injured tissues: MiRNA-380-5p promotes epithelial regeneration and tissue growth via down regulation of its target gene. Thus, pharmacological formulations encompassing “MiRNA-380-5p or its activators” may be used to promote regeneration and healing of injured tissues.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, MiRNA-based regenerative therapy for Injured tissues: MiRNA-380-5p promotes epithelial regeneration and tissue growth via downregulation of its target gene, 14/March/2015, 06.04 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
Undisclosed information: How MiRNA-380-5p promotes regeneration of injured tissues.